Health Condition 1: S902- Contusion of toe with damage to nail Health Condition 2: S720- Fracture of head and neck of femur Health Condition 3: S823- Fracture of lower end of tibia Health Condition 4: S820- Fracture of patella Health Condition 5: S822- Fracture of shaft of tibia Health Condition 6: S821- Fracture of upper end of tibia Health Condition 7: S998- Other specified injuries of ankleand foot Health Condition 8: S722- Subtrochanteric fracture of femur Health Condition 9: S729- Unspecifi
Conditions
Interventions
Intervention1: Injection glycopyrrolate: Injection glycopyrrolate 0.2 mg intramuscular in deltoid region to be given 15 minutes before indiction of spinal anaesthesia
Control Intervention1: 0.9 % Norm
Sponsors
Dr Neetesh Gautam
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patient giving consent to participate in study 2 Age between 60-80 years 3 Weight between 50-80 kg 4 ASA grade I and II
Exclusion criteria
Exclusion criteria: 1 Patients not giving consent to participate in the study. 2 ASA grade III and IV 3 Patients with respiratory, cardiovascular, renal diseases, obesity and pregnancy. 4 Age below 80 years. 5 Weight below
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prophylactic intramuscular glycopyrrolate significantly reduced the incidence of hypotension during spinal anesthesia when compared with the control group.Timepoint: 15 minutes before induction of spinal anaesthesia till completion of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Intramuscular route is safer than intravenous route as abrupt tachycardia is not associated with it.Timepoint: 15 minutes before induction of spinal anaesthesia till completion of surgery | — |
Countries
India
Contacts
Public ContactDr Preeti Goyal
Gajra Raja Medical college
Outcome results
None listed